{
  "top": {
    "transparent": false,
    "minPrice": 0,
    "maxPrice": 0,
    "minFloat": 0,
    "maxFloat": 0,
    "minScore": 0,
    "maxScore": 0,
    "minVolume": 0,
    "maxVolume": 0,
    "lists": {
      "session": {
        "Price": false,
        "ChangePercent": true,
        "FiveM": false,
        "Float": false,
        "Volume": false,
        "SprPercent": false,
        "Time": false,
        "HighOfDay": false,
        "News": false,
        "Count": true,
        "Score": true,
        "Bonuses": true
      },
      "daily": {
        "Price": true,
        "ChangePercent": true,
        "FiveM": true,
        "Float": true,
        "Volume": true,
        "SprPercent": true,
        "Time": true,
        "HighOfDay": true,
        "News": true,
        "Count": true,
        "Score": true,
        "Bonuses": true,
        "length": 5
      }
    }
  },
  "news": {
    "showTrackedTickers": true,
    "filteredTickers": [
      "NAAS",
      "MLGO",
      "VMAR",
      "NKGN",
      "TANH",
      "SLRN",
      "HOLO",
      "CELH",
      "IONQ",
      "HMR",
      "MGTX",
      "NIXX",
      "LTRY",
      "QBTS",
      "TLSA",
      "OSRH",
      "PRPH",
      "STAI",
      "RZLV",
      "SOBR",
      "KITT",
      "TALK",
      "JG",
      "AIFF",
      "WIMI",
      "VIPS",
      "RTC",
      "USEG",
      "ACXP",
      "INOD",
      "CYD",
      "ASST",
      "TNMG",
      "MX",
      "EDIT",
      "FUBO",
      "JMIA",
      "ARBE",
      "TUYA",
      "MVIS",
      "ALLO",
      "LNZA",
      "GOTU",
      "PAGS"
    ],
    "blockList": [
      "US Stocks Likely To Open Lower After Gaining For 2 Days",
      "Market-Moving News for",
      "What's Going On",
      "Why Five9"
    ],
    "bullishList": [
      "FDA Approves",
      "Clinical Trials",
      "Noteworthy Insider Activity",
      "FDA Approval Granted",
      "Drug Trial Success",
      "Phase 3 Trial Results",
      "Breakthrough Therapy Designation",
      "Biotech Approval",
      "Positive Data from Clinical Study",
      "SEC Investigation Dropped",
      "Regulatory Approval Granted",
      "Government Contract Secured",
      "Lawsuit Settlement Reached",
      "Initiates Coverage",
      "Buy Rating",
      "Strong Buy",
      "Price Target Raised",
      "Upgrades to Buy",
      "Raises Price Target",
      "Maintains Overweight Rating",
      "Reiterates Buy",
      "New Wall Street Coverage",
      "Stock Upgrade",
      "Top Pick",
      "Bullish Call",
      "Underweight to Overweight",
      "Hedge Fund Buys",
      "Institutional Ownership Increases",
      "Buffett Increases Stake",
      "ARK Invest Adds",
      "Large Insider Purchase",
      "CEO Buys",
      "10% Owner Acquires",
      "Earnings Beat Expectations",
      "Revenue Surprise",
      "Raises Guidance",
      "Record Revenue",
      "Merger Announced",
      "Strategic Partnership",
      "Joint Venture Agreement",
      "Government Contract Awarded",
      "Short Interest at Record High",
      "Short Squeeze Potential",
      "Unusual Options Activity",
      "Massive Call Buying",
      "Dark Pool Order Detected",
      "Unusual Trading Volume",
      "Share Repurchase",
      "Board Of Directors Has Approved"
    ],
    "bearishList": [
      "Sell Alert",
      "Stock Downgrade",
      "Downgrades to Sell",
      "Lowers Price Target",
      "Underperform Rating",
      "Bearish Call",
      "To Acquire",
      "Snaps Up",
      "Takeover Attempt",
      "Exploring Strategic Alternatives",
      "CEO Sells",
      "Large Insider Selling",
      "Hedge Fund Exits",
      "Institutional Ownership Decreases",
      "Revenue Miss",
      "Earnings Miss",
      "Lowers Guidance",
      "Regulatory Investigation",
      "SEC Investigation Launched",
      "Short Report Released"
    ],
    "allowMultiSymbols": false
  }
}